Development of genetic hypotheses in essential hypertension

[1]  H. S. Kim,et al.  Importance of quantitative genetic variations in the etiology of hypertension. , 2000, Kidney international.

[2]  O. Scremin,et al.  Hypertension in β-Adducin–Deficient Mice , 2000 .

[3]  W. Siffert.  G protein β3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy , 2000 .

[4]  D. Rosskopf,et al.  G Protein β3 Gene: Structure, Promoter, and Additional Polymorphisms , 2000 .

[5]  F. Luft,et al.  Molecular genetics of human hypertension. , 1998, Current opinion in cardiology.

[6]  J. Lalouel,et al.  Elements of a paracrine tubular renin-angiotensin system along the entire nephron. , 1999, Hypertension.

[7]  D. Rosskopf,et al.  Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. , 1999, Journal of the American Society of Nephrology : JASN.

[8]  Y. Toya,et al.  Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. , 1999, Hypertension.

[9]  W. Siffert,et al.  G protein beta3 subunit 825T allele and its potential association with obesity in hypertensive individuals. , 1999, Journal of hypertension.

[10]  D. Stec,et al.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. , 1999, Physiological genomics.

[11]  X. Jeunemaître,et al.  Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. , 1999, Hypertension.

[12]  D. Grobbee,et al.  Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene. , 1999, American journal of hypertension.

[13]  H. Knigge,et al.  Increased frequency of G-protein beta 3-subunit 825 T allele in dialyzed patients with type 2 diabetes. , 1999, Kidney international.

[14]  M D'Amico,et al.  Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. , 1999, Hypertension.

[15]  X. Jeunemaître,et al.  Role of Cysteine Residues in Human Angiotensinogen , 1998, The Journal of Biological Chemistry.

[16]  N. Cook,et al.  Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. , 1998, Hypertension.

[17]  L. Vesci,et al.  PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. , 1998, The Journal of pharmacology and experimental therapeutics.

[18]  R. Kunz,et al.  Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. , 1997, Hypertension.

[19]  J. Lalouel,et al.  Angiotensinogen T235 expression is elevated in decidual spiral arteries. , 1997, The Journal of clinical investigation.

[20]  John Quackenbush,et al.  A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. , 1997, The Journal of clinical investigation.

[21]  H. Schunkert,et al.  The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. , 1997, Hypertension.

[22]  G. Bianchi,et al.  Renal Na,K-ATPase in genetic hypertension. , 1996, Hypertension.

[23]  D. Rosskopf,et al.  Selectively enhanced cellular signaling by Gi proteins in essential hypertension. G alpha i2, G alpha i3, G beta 1, and G beta 2 are not mutated. , 1996, Circulation research.

[24]  X. Jeunemaître,et al.  The role of intermediate phenotypes in essential hypertension: non-modulation as a model. , 1996, Endocrine research.

[25]  F. Valtorta,et al.  Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. , 1996, The Journal of clinical investigation.

[26]  R. Lifton.  Molecular Genetics of Human Blood Pressure Variation , 1996, Science.

[27]  J. Lalouel,et al.  Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity , 1996, Journal of hypertension.

[28]  T. Wieland,et al.  Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. , 1995, The Journal of clinical investigation.

[29]  H. S. Kim,et al.  Genetic control of blood pressure and the angiotensinogen locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Macciardi,et al.  Association of the α-Adducin Locus With Essential Hypertension , 1995 .

[31]  D. Cusi,et al.  Two point mutations within the adducin genes are involved in blood pressure variation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. S. Kim,et al.  Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Lalouel,et al.  Angiotensinogen as a risk factor for essential hypertension in Japan. , 1994, The Journal of clinical investigation.

[34]  D. Rosskopf,et al.  Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension. , 1993, The Journal of clinical investigation.

[35]  J. Lalouel,et al.  A molecular variant of angiotensinogen associated with preeclampsia , 1993, Nature Genetics.

[36]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[37]  P. Ferrari,et al.  Ouabainlike factor in Milan hypertensive rats. , 1992, The American journal of physiology.

[38]  S. Hunt,et al.  Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension , 1992, Nature Genetics.

[39]  J. Rapp.  Dissecting the Primary Causes of Genetic Hypertension in Rats , 1991, Hypertension.

[40]  G. Borsani,et al.  Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain. , 1991, Biochemical and Biophysical Research Communications - BBRC.

[41]  G. Borsani,et al.  Erythrocyte adducin differential properties in the normotensive and hypertensive rats of the Milan strain. Characterization of spleen adducin m-RNA. , 1989, American journal of hypertension.

[42]  J. Ingelfinger,et al.  Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. , 1986, The Journal of clinical investigation.

[43]  A. Persson,et al.  Increased tubuloglomerular feedback activity in Milan hypertensive rats. , 1986, The American journal of physiology.

[44]  K. Gardner,et al.  A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification. , 1986, The Journal of biological chemistry.

[45]  G. Bianchi,et al.  Red blood cell abnormalities and spontaneous hypertension in the rat. A genetically determined link. , 1985, Hypertension.

[46]  A. Giovanetti,et al.  Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. , 1974, Clinical science and molecular medicine.

[47]  G. Bianchi,et al.  The hypertensive role of the kidney in spontaneously hypertensive rats. , 1973, Clinical science and molecular medicine. Supplement.

[48]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[49]  D. Rosskopf,et al.  G protein beta 3 gene: structure, promoter, and additional polymorphisms. , 2000, Hypertension.

[50]  G. Bianchi,et al.  Genetic mechanisms underlying the regulation of urinary sodium excretion and arterial blood pressure: the role of adducin. , 2000, Acta physiologica Scandinavica.

[51]  J. Staessen,et al.  M235T angiotensinogen gene polymorphism and cardiovascular renal risk. , 1999, Journal of hypertension.

[52]  A Kumar,et al.  Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. , 1999, Hypertension.

[53]  P. Manunta,et al.  Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. , 1999, The American journal of physiology.

[54]  L. Hansson.  The Hypertension Optimal Treatment study and the importance of lowering blood pressure. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[55]  Arya M. Sharma,et al.  Association of a human G-protein β3 subunit variant with hypertension , 1998, Nature Genetics.

[56]  L Zagato,et al.  Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. , 1997, Lancet.

[57]  F. Macciardi,et al.  Association of the alpha-adducin locus with essential hypertension. , 1995, Hypertension.

[58]  F. Cambien,et al.  The application of molecular genetics to the study of familial arterial hypertension. , 1990, Advances in nephrology from the Necker Hospital.

[59]  Arthur C. Guyton,et al.  Arterial Pressure And Hypertension , 1980 .